Data from 3,554 breast cancer patients revealed a significant association between low CDK5RAP3 expression and poor overall survival (HR = 1.61; p = 3.6 × 10−4) and relapse-free survival (HR = 1.64; p < 10−16, Figure 4A,B). Here, CDK5RAP3 is linked to breast carcinoma.